Chemical Engine

DeNovaMed has a particularly strong team in computer-aided drug design. Utilizing “de novo” molecular modeling techniques, they have developed multiple classes of antibacterial compounds that are drug-like, yet have no structural features in common with older antibiotics. These small molecule inhibitors of lipid metabolism enzymes have great inherent advantages in keeping resistance from developing in the future.